Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Oxford Biomedica

Biotech & Life Sciences · Oxford, United Kingdom · Founded 1995 · IPO 2008 Unicorn

Viral vector development and manufacturing for therapies

Valuation
$1.03B
Market cap · May/2026
Revenue
$224M
Latest reported FY
EBITDA
$30M
Latest reported FY

Investors

2 investors on Oxford Biomedica's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 2 investors entered at this stage
University of Oxford
Oxford University Innovation

Global footprint

Where Oxford Biomedica has talent and traffic

Workforce by country
11 countries with
team presence
🇬🇧 United Kingdom71.3%
🇫🇷 France14.3%
🇺🇸 United States12.7%
🇩🇪 Germany0.5%
🇨🇭 Switzerland0.2%
Top 5 of 11 shown
Web traffic by country
29K monthly visits
across markets
🇬🇧 United Kingdom21.4%
🇺🇸 United States12.8%
🇮🇳 India5.5%
🇫🇷 France4.8%
🇪🇸 Spain2.1%
Top 5 markets shown

Patent intelligence

$20M patent portfolio · 28 active families

Estimated portfolio value
$20M
1.9% of market cap · 39.8× smaller than top peer BioNTech ($780M)
28 active patent families
Where Oxford Biomedica innovates Molecular biologyVirusBioinformaticsCapsidAdeno-associated virus

Where Oxford Biomedica concentrates vs peers

Each axis is a top-10 topic across Oxford Biomedica and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Oxford Biomedica

An AI-synthesized read of the highest-engagement posts about Oxford Biomedica on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Oxford Biomedica on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.